December 8, 2022

Medical Trend

Medical News and Medical Resources

COVID-19 oral drug significantly reduces infection mortality in the elderly

COVID-19 oral drug significantly reduces infection mortality in the elderly



 

The Lancet: COVID-19 oral drug significantly reduces infection mortality in the elderly.


On October 8, The Lancet published an article “Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study”, which is the largest real-world study on the effectiveness of two COVID-19 oral drugs in the treatment of Omicron variant strain infection.

 

COVID-19 oral drug significantly reduces infection mortality in the elderlySource: DOI: https://doi.org/10.1016/S0140-6736(22)01586-0

 

The research data comes from 1,074,856 community-infected patients in Hong Kong in 2022.

After screening, 4,983 molnupiravir users and 5,542 Paxlovid users were included in the statistics, of which 9,176 were older than 60 years old (87.1%) and completed the full course of vaccination. of only 2,650 (22.4%) .

 

That is to say, most of them belong to the high-risk group of COVID-19 infection – advanced age and unvaccinated.

 

The study found that the use of two COVID-19 drugs in the early stage of infection can significantly reduce the risk of disease progression and death in the elderly. Among them, the COVID-19 oral drug Paxlovid reduced the risk of death after hospitalization in the elderly by 79%.

 

COVID-19 oral drug significantly reduces infection mortality in the elderly

Source: DOI: https://doi.org/10.1016/S0140-6736(22)01586-0

 

 

(source:internet, reference only)


Disclaimer of medicaltrend.org